lymphoma B cells tyrosine kinase activation in chronic lymphocytic leukemia and receptor signaling despite absent or inefficient - ZAP-70 enhances B-cell

[1]  M. Nussenzweig,et al.  Igβ tyrosine residues contribute to the control of B cell receptor signaling by regulating receptor internalization , 2006, The Journal of experimental medicine.

[2]  L. Miosge,et al.  Essential role of membrane cholesterol in accelerated BCR internalization and uncoupling from NF-κB in B cell clonal anergy , 2006, The Journal of experimental medicine.

[3]  M. Chilosi,et al.  ZAP-70 is expressed by normal and malignant human B-cell subsets of different maturational stage , 2006, Leukemia.

[4]  T. Kipps,et al.  ZAP-70 is a novel conditional heat shock protein 90 (Hsp90) client: inhibition of Hsp90 leads to ZAP-70 degradation, apoptosis, and impaired signaling in chronic lymphocytic leukemia. , 2005, Blood.

[5]  B. Malissen,et al.  Selective Defect in Antigen-Induced TCR Internalization at the Immune Synapse of CD8 T Cells Bearing the ZAP-70(Y292F) Mutation1 , 2005, The Journal of Immunology.

[6]  A. Weiss,et al.  Intramolecular Regulatory Switch in ZAP-70: Analogy with Receptor Tyrosine Kinases , 2005, Molecular and Cellular Biology.

[7]  F. Brodsky,et al.  Plasticity of B cell receptor internalization upon conditional depletion of clathrin. , 2005, Molecular biology of the cell.

[8]  L. Rassenti,et al.  ZAP-70 directly enhances IgM signaling in chronic lymphocytic leukemia. , 2005, Blood.

[9]  P. De,et al.  Molecular Basis for a Direct Interaction between the Syk Protein-tyrosine Kinase and Phosphoinositide 3-Kinase* , 2005, Journal of Biological Chemistry.

[10]  P. Chiusolo,et al.  Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells. , 2004, Blood.

[11]  Arthur Weiss,et al.  ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. , 2004, The New England journal of medicine.

[12]  K. Rai,et al.  Clinical staging and prognostic markers in chronic lymphocytic leukemia. , 2004, Hematology/oncology clinics of North America.

[13]  F. Stevenson,et al.  Chronic lymphocytic leukemia: revelations from the B-cell receptor. , 2004, Blood.

[14]  N. Chiorazzi,et al.  B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor. , 2003, Annual review of immunology.

[15]  S. Pierce,et al.  Cbl-b Negatively Regulates B Cell Antigen Receptor Signaling in Mature B Cells through Ubiquitination of the Tyrosine Kinase Syk , 2003, The Journal of experimental medicine.

[16]  Emili Montserrat,et al.  ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. , 2003, The New England journal of medicine.

[17]  D. Oscier,et al.  Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia. , 2003, Blood.

[18]  Arthur Weiss,et al.  Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia. , 2002, Blood.

[19]  M. Naramura,et al.  c-Cbl and Cbl-b regulate T cell responsiveness by promoting ligand-induced TCR down-modulation , 2002, Nature Immunology.

[20]  H. Niiro,et al.  Decision making in the immune system: Regulation of B-cell fate by antigen-receptor signals , 2002, Nature Reviews Immunology.

[21]  David Botstein,et al.  Relation of Gene Expression Phenotype to Immunoglobulin Mutation Genotype in B Cell Chronic Lymphocytic Leukemia , 2001, The Journal of experimental medicine.

[22]  E. Cesarman,et al.  Survival of leukemic B cells promoted by engagement of the antigen receptor. , 2001, Blood.

[23]  C. Elly,et al.  Cbl Promotes Ubiquitination of the T Cell Receptor ζ through an Adaptor Function of Zap-70* , 2001, The Journal of Biological Chemistry.

[24]  T J Hamblin,et al.  Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. , 1999, Blood.

[25]  N. Chiorazzi,et al.  Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. , 1999, Blood.

[26]  C. Elly,et al.  A direct interaction between the adaptor protein Cbl-b and the kinase Zap-70 induces a positive signal in T cells , 1999, Current Biology.

[27]  H. Band,et al.  Cbl-mediated Negative Regulation of the Syk Tyrosine Kinase , 1998, The Journal of Biological Chemistry.

[28]  A. Weiss,et al.  The Syk family of protein tyrosine kinases in T‐cell activation and development , 1998, Immunological reviews.

[29]  G Waksman,et al.  Structural basis for Syk tyrosine kinase ubiquity in signal transduction pathways revealed by the crystal structure of its regulatory SH2 domains bound to a dually phosphorylated ITAM peptide. , 1998, Journal of molecular biology.

[30]  A. Isacchi,et al.  Tyrosine 474 of ZAP-70 Is Required for Association with the Shc Adaptor and for T-cell Antigen Receptor-dependent Gene Activation* , 1998, The Journal of Biological Chemistry.

[31]  Juan Zhang,et al.  A unique insert in the linker domain of Syk is necessary for its function in immunoreceptor signalling , 1998, The EMBO journal.

[32]  P. Galieni,et al.  Expression of the T-cell-specific tyrosine kinase Lck in normal B-1 cells and in chronic lymphocytic leukemia B cells. , 1998, Blood.

[33]  V. Lang,et al.  Normal Syk protein level but abnormal tyrosine phosphorylation in B-CLL cells , 1997, Leukemia.

[34]  S. Schreiber,et al.  Proximity and orientation underlie signaling by the non‐receptor tyrosine kinase ZAP70 , 1997, The EMBO journal.

[35]  Jun Wu,et al.  The Vav Binding Site (Y315) in ZAP-70 Is Critical for Antigen Receptor–mediated Signal Transduction , 1997, The Journal of experimental medicine.

[36]  A. Weiss,et al.  Enhancement of lymphocyte responsiveness by a gain-of-function mutation of ZAP-70 , 1996, Molecular and cellular biology.

[37]  A. Veillette,et al.  Differential Intrinsic Enzymatic Activity of Syk and Zap-70 Protein-tyrosine Kinases* , 1996, The Journal of Biological Chemistry.

[38]  M. Grever,et al.  National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. , 1996, Blood.

[39]  M. Fournel,et al.  Association of tyrosine protein kinase Zap-70 with the protooncogene product p120c-cbl in T lymphocytes , 1996, The Journal of experimental medicine.

[40]  T. Kurosaki,et al.  Reconstitution of Syk function by the ZAP-70 protein tyrosine kinase. , 1995, Immunity.

[41]  R. Aebersold,et al.  Identification by electrospray ionization mass spectrometry of the sites of tyrosine phosphorylation induced in activated Jurkat T cells on the protein tyrosine kinase ZAP-70. , 1994, The Journal of biological chemistry.

[42]  G. Leone,et al.  Comparison of ZAP-70/Syk mRNA levels with immunoglobulin heavy-chain gene mutation status and disease progression in chronic lymphocytic leukemia. , 2005, Haematologica.